Cargando…
Repeated doses of Praziquantel in Schistosomiasis Treatment (RePST) – single versus multiple praziquantel treatments in school-aged children in Côte d’Ivoire: a study protocol for an open-label, randomised controlled trial
BACKGROUND: Large scale administration of the anthelminthic drug praziquantel (PZQ) to at-risk populations is the cornerstone of schistosomiasis control, although persisting high prevalence of infections in some areas and growing concerns of PZQ resistance have revealed the limitations of this strat...
Autores principales: | Hoekstra, P. T., Casacuberta Partal, M., Amoah, A. S., van Lieshout, L., Corstjens, P. L. A. M., Tsonaka, S., Assaré, R. K., Silué, K. D., Meité, A., N’Goran, E. K., N’Gbesso, Y. K., Roestenberg, M., Knopp, S., Utzinger, J., Coulibaly, J. T., van Dam, G. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295059/ https://www.ncbi.nlm.nih.gov/pubmed/30547750 http://dx.doi.org/10.1186/s12879-018-3554-2 |
Ejemplares similares
-
Efficacy of single versus four repeated doses of praziquantel against Schistosoma mansoni infection in school-aged children from Côte d'Ivoire based on Kato-Katz and POC-CCA: An open-label, randomised controlled trial (RePST)
por: Hoekstra, Pytsje T., et al.
Publicado: (2020) -
Limited efficacy of repeated praziquantel treatment in Schistosoma mansoni infections as revealed by highly accurate diagnostics, PCR and UCP-LF CAA (RePST trial)
por: Hoekstra, Pytsje T., et al.
Publicado: (2022) -
Efficacy and Safety of Praziquantel in Preschool-Aged Children in an Area Co-Endemic for Schistosoma mansoni and S. haematobium
por: Coulibaly, Jean T., et al.
Publicado: (2012) -
Sustaining Control of Schistosomiasis Mansoni in Western Côte d’Ivoire: Results from a SCORE Study, One Year after Initial Praziquantel Administration
por: Assaré, Rufin K., et al.
Publicado: (2016) -
Praziquantel, Mefloquine-Praziquantel, and Mefloquine-Artesunate-Praziquantel against Schistosoma haematobium: A Randomized, Exploratory, Open-Label Trial
por: Keiser, Jennifer, et al.
Publicado: (2014)